Melissa A. Geller, MD

Trials

Studies that name Melissa A. Geller, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:18 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT00652899 · Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer

  Masonic Cancer Center, University of Minnesota · terminated · Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer · principal investigator
• N/A
  NCT00536523 · Effect of Serotonin Level on Constipation Caused by Chemotherapy in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

  University of Minnesota · terminated · Constipation, Bowel Obstruction, Fallopian Tube Cancer · study chair
• Ph2
  NCT00331422 · Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

  Masonic Cancer Center, University of Minnesota · terminated · Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer · study chair
• Ph2
  NCT00319748 · Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers

  Masonic Cancer Center, University of Minnesota · completed · Breast Cancer, Ovarian Cancer, Endometrial Cancer · principal investigator
• Ph2
  NCT00258362 · Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer

  Masonic Cancer Center, University of Minnesota · completed · Endometrial Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:18 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.